The fact that PTP1B can play both negative and positive roles in different signaling pathways makes it an interesting therapeutic target and has thus attracted attention for the discovery and use of PTP1B modulators in diabetes, obesity and possibly cancer [4]. This evidence concerns the gene PTPN1 and obesity disorder.